Key result
Corrected serum calcium shows a borderline nonlinear link with mortality in multivessel CAD.
Why the study?
Serum calcium has been associated with cardiovascular outcomes, but its relationship with mortality in mitral valve disease was unclear.
Is albumin-corrected serum calcium associated with all-cause mortality in older adults with moderate-to-severe mitral valve disease?
Cohort (n=1,470)
Yes
Is albumin-corrected serum calcium associated with all-cause mortality in older adults with moderate-to-severe mitral valve disease?
In older adults with moderate-to-severe mitral valve disease, albumin-corrected serum calcium is only weakly and non-monotonically associated with 1-year mortality, whereas lower serum albumin is a much stronger independent predictor of death.
Answers are grounded in this paper and cite their sources.
Should not change calcium management in mitral valve disease; leaves open nutritional status as a prognostic target.
Serum calcium has been associated with cardiovascular outcomes, but its relationship with mortality in mitral valve disease (MVD) is unclear. We examined the association between albumin-corrected serum calcium and all-cause mortality in older adults with moderate-to-severe MVD using restricted cubic spline (RCS) analysis. This prospective, multicentre cohort study used data from the China-DVD registry (ClinicalTrials.gov, NCT02865798). Patients aged ≥ 60 years with moderate-to-severe MVD were included; those with moderate-to-severe disease of other valves, previous valve surgery, infective endocarditis, missing or non-physiological laboratory values, or missing vital status were excluded. The primary outcome was all-cause mortality. Albumin-corrected calcium was calculated with the Payne formula. The primary adjusted model was prespecified to be parsimonious (corrected calcium, age, sex, coronary artery disease, pulmonary hypertension, left ventricular ejection fraction; 6 parameters, 19.0 events per parameter). Calcium was modelled as a 2-degree-of-freedom RCS with 3 knots at the 10th, 50th and 90th percentiles, and as quartiles. Twelve sensitivity analyses, including 1 retaining all observed values and a 30-day landmark analysis, were performed. Of 2,158 eligible patients, 1470 were analysed (mean age 69.5 ± 7.2 years; 47.7% men) and 114 deaths (7.8%) occurred during a median follow-up of 365 days (IQR 208–383). Mean albumin-corrected calcium was 9.00 ± 0.48 mg/dL. The spline showed a shallow non-monotonic association with the lowest risk at 8.9–9.0 mg/dL (overall association P = 0.107; nonlinearity P = 0.050). Risk was increased in the upper tail (9.8 mg/dL vs 9.0 mg/dL: HR 1.58, 95% CI 1.00–2.50; 10.2 mg/dL: HR 2.12, 95% CI 1.01–4.44), whereas lower tail estimates were compatible with the null. No quartile contrast was significant (highest vs lowest quartile: HR 1.35, 95% CI 0.84–2.16). Evidence of nonlinearity was present in only some sensitivity analyses and was attenuated after additional adjustment for albumin ( P = 0.042; quartile HR 1.20, 95% CI 0.75–1.93). Serum albumin was more strongly associated with mortality (HR 2.24 per 1 g/dL lower, 95% CI 1.45–3.46, P < 0.001), and serum phosphorus showed a borderline positive association (HR 1.21 per mg/dL, 95% CI 1.01–1.47, P = 0.043). In older adults with moderate-to-severe MVD, albumin-corrected serum calcium showed a shallow non-monotonic association with all-cause mortality, with the lowest risk near 8.9–9.0 mg/dL. The evidence for nonlinearity was borderline, no quartile contrast was significant, and the signal was attenuated after adjustment for albumin. These findings should therefore be regarded as hypothesis generating rather than as confirmation of an independent U-shaped association. Serum albumin was more strongly and consistently associated with mortality, and the calcium signal may partly reflect the prognostic information carried by albumin and by nutritional and inflammatory status. Trial registration ClinicalTrials.gov, NCT02865798; registered on 12 August 2016.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2026) conducted a cohort in Moderate-to-severe mitral valve disease (n=1,470). Albumin-corrected serum calcium vs. Lowest quartile or reference level (8.9-9.0 mg/dL) was evaluated on All-cause mortality (HR 1.35, 95% CI 0.84-2.16, p=0.107). Albumin-corrected serum calcium showed a borderline nonlinear association with all-cause mortality in MVD.
Synapse has enriched 10 related papers. Consider them for comparative context: